ANA Screen ELISA Kit (Antinuclear Antibody)


Human ANA screen ELISA kit is designed for screening in vitro quantitative concentrations of IgG autoantibodies to nuclear antigens (antinuclear antibodies, ANA screen) in human serum or plasma. This assay has a minimum analytical sensitivity limit of diagn. 96.4%.

A mixture of purified antigens SS-A 60, SS-A 52, SS-B, RNP-70, Sm, RNP/Sm, Scl-70, Centromere B and Jo-1 is coated on to microwells.


Antinuclear antibodies (ANA) are present in the blood of individuals that have group of autoimmune disorders usually referred to as connective tissue diseases (CTD). They are a specific class of autoantibodies which can bind and destroy certain structures within the nucleus of the cells. They have a number of different subtypes which include anti-histone, anti-sp100, anti-centromere, anti-Scl-70, anti-Ro, anti-La, anti-nRNP, anti-Sm and anti-dsDNA antibodies.

Initially, screening is carried out using a generic assay which detects human ANA of a broad specificity or indirect immunofluorescence tests. If positive, then more specific tests are carried out based on these findings. These more specific antigen have the ability to react with single auto-antigens for example: Sm/RNP, SS-B/La, dsDNA, Scl-70, Sm, SS-A/Ro etc.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Divisible Microplate: Anti-nuclear antibodies (ANA screen) are bound to microwells.
  • Calibrator And Control Negative.
  • Sample Buffer (5x).
  • Enzyme Conjugate.
  • Substrate: Tetramethylbenzidin (TMB).
  • Stop Solution.
  • Wash Buffer (50x Concentrate).
  • Instruction For Use.
  • Certificate Of Analysis.


The minimum detection sensitivity level of IgG autoantibodies to human anti-nuclear antibodies (ANA, antinuclear antibodies) using current ANA ELISA kit was diagn. 96.4%.The dynamic range for this assay is cut-off index 1.0.


– Expected Values: In a normal range = Cut-off Index 1.0, Positive = > 1.2, Border Line = 1.0 – 1.2, Negative = < 1.0.
– Linearity: 90 – 110%
– Intra Assay Precision: 2.2 – 3.5%
– Inter Assay Precision: 3.8 – 6.5%
– Clinical Diagnosis: Sensitivity (96.4%), Specificity (98.0%), Overall agreement (97.3%).


  1. Performance of antinuclear antibody connective tissue disease screen. Ann N Y Acad Sci. (2007) 1109: 322-9. López-Hoyos M., et al.
  2. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases. Ann N Y Acad Sci. (2007) 1109: 407-13. Ghillani P., et al.
  3. ANA screening: an old test with new recommendations. Ann Rheum Dis. (2010) 69 (8): 1420-2. Meroni P.L. and Schur P.H.
  4. ANA testing in the presence of acute and chronic infections. J Immunoassay Immunochem. (2016) 37 (5): 439-52. Review. Litwin C.M. and Binder S.R.
  5. Antinuclear antibody screening by ELISA and IF techniques: discrepant results in juvenile idiopathic arthritis but consistency in childhood systemic lupus erythematous. Clin Rheumatol. (2014) 33 (5): 643-7. Spârchez M., et al.


  • Full Name: ANA Screen ELISA Kit (Antinuclear Antibody)
  • Reactivity: Human
  • Sample Type: Serum, Plasma
  • Sensitivity: 96.4%


Online Enquiry Form

"*" indicates required fields

Please check mark information required:


Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford